Vaccitech
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Vaccitech generated cash of -$14,431,000, which is more than the previous year. Cash used in financing activities reached the amount of $325,000 last year. Net change in cash is therefore -$19,669,000.

Cash Flow

Vaccitech plc (NASDAQ:VACC): Cash Flow
2019 -18.68M -124.35K 2.04M
2020 -11.02M -292.77K 41.43M
2021 -32.58M -12.91M 222.74M
2022 -14.43M -5.75M 325K

VACC Cash Flow Statement (2019 โ€“ 2022)

2022 2021 2020 2019
Cash at beginning of period
214.05M43.26M11.43M28.63M
Operating activities
Net income
5.32M-51.11M-17.93M-20.72M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
4.32M602K208.39K345.43K
Stock-based compensation expense
9.87M16.48M3.62M830.60K
Deferred income tax benefit 9.87M16.48M3.62M830.60K
Changes in operating assets and liabilities:
Accounts receivable, net
-5.83M559K478.43K-959.19K
Inventories
0-4.14M928.92K0
Accounts payable
1.14M-3.52M585.99K0
Cash generated by operating activities
-14.43M-32.58M-11.02M-18.68M
Investing activities
Purchases Of Investments
0000
Investments In Property Plant And Equipment
-6.13M-1.14M-292.77K-127.81K
Acquisitions Net
0-11.76M00
Cash generated by investing activities
-5.75M-12.91M-292.77K-124.35K
Financing activities
Common Stock Issued
484K102.77M490
Payments for dividends
0000
Repurchases of common stock
0000
Repayments of term debt
0000
Cash used in financing activities
325K222.74M41.43M2.04M
Net Change In Cash
-19.66M170.78M31.83M-17.20M
Cash at end of period
194.38M214.05M43.26M11.43M
Data sourceData source